Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

ClinicalTrials.gov ID: NCT01329978

Public ClinicalTrials.gov record NCT01329978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 2:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The ATOMIC Study: A Multicenter, Open-label, Randomized, Duration Finding Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Oral Administration of PSI-7977 in Combination With Pegylated Interferon and Ribavirin in Treatment-Naive Patients With Chronic HCV Infection Genotype 1,4, 5, or 6

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety, tolerability, and efficacy of sofosbuvir (GS-7977; PSI-7977) administered in combination with pegylated interferon and ribavirin (PEG/RBV) in treatment-naive patients with HCV genotypes 1,4,5,6, or indeterminate genotype.

Study identification

NCT ID
NCT01329978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
332 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Jul 31, 2012
Completion
Jul 31, 2012
Last update posted
May 25, 2014

2011 – 2012

United States locations

U.S. sites
44
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
Alabama Liver and Digestive Specialist Montgomery Alabama 36116
Clopton Clinic Jonesboro Arkansas 72401
Advanced Clinical Research Institute Anaheim California 92801
Providence Clinical Research Burbank California 91505
Southern California Liver Centers Coronado California 92118
Cedars Sinai Medical Center Los Angeles California 90048
eStudy Site Oceanside California 92056
Desta Digestive Disease Medical Center San Diego California 92114
Medical Associates Reseach Group San Diego California 92123
Kaiser Permanente Hepatology Research San Diego California 92154
University of Colorado Denver Transplant Center and Hepatology Clinic Aurora Colorado 80045
South Denver Gastreoenterology Englewood Colorado 80110
Pointe West Infectious Disease Bradenton Florida 34209
Avail Clinical Research DeLand Florida 32720
University of Florida College of Medicine Gainesville Florida 32610
Orlando Immunology Center Orlando Florida 32803
Internal Medicine Specialists Orlando Florida 32806
Advanced Research Institute Trinity Florida 34655
South Florida Center of Gastroenterology Wellington Florida 33414
Atlanta Gastroenterology Associates Atlanta Georgia 30308
Gastrointestinal Specialists of Georgia Marietta Georgia 30060
University of Chicago Medical Center Chicago Illinois 60637
Investigative Clinical Research Annapolis Maryland 21401
Clinical Associates Research Reisterstown Maryland 21136
Beth Israel Deconess Medical Center Boston Massachusetts 02215
U Mass Memorial Medical Center Worcester Massachusetts 01655
Henry Ford Health System Novi Michigan 48377
St. Louis University Gastroenterology and Hepatology Clinical Research St Louis Missouri 63104
University of New Mexico Health Science Center Albuquerque New Mexico 87131
North Shore University Hospital Manhasset New York 11303
Concorde Medical Group New York New York 10016
New York Presbyterian Hospital New York New York 10021
Mt. Sinai Medical Center New York New York 10029
Asheville Gastroenterology Associates Asheville North Carolina 28801
Duke University Medical Center Durham North Carolina
University of Cincinnati Cincinnati Ohio 45267
Columbia Gastroenterology Associates Columbia South Carolina 29204
North Texas Research Institute Arlington Texas 76012
Central Texas Cinical Research Austin Texas 78705
Baylor University Dallas Texas 75246
Baylor/ St. Luke's Advanced Liver Therapy Houston Texas 77030
Alamo Medical Research San Antonio Texas 78215
Digestive and Liver Disease Specialist Norfolk Virginia 23502
Virginia Mason Medical Center Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01329978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 25, 2014 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01329978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →